The new data will help researchers train next-generation AI models that are applicable to ethnically and demographically ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

Acrivon Therapeutics, Inc. (NASDAQ: ACRV), a clinical stage biopharmaceutical company with a market capitalization of $184 million and an impressive 60% stock return over the past year, announced that ...

Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...

The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.

Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...

The in-house salon for patients at Roswell Park will now be called the New Era Cap Foundation Elevate Salon. BUFFALO, N.Y. — ...

Often referred to as the "change of life," menopause marks a significant change for women. As you approach your mid-40s, you may begin to notice subtle shifts in your body, such as irregular ...

Genetics significantly impact cancer risk, particularly in inherited mutations like BRCA1/BRCA2, which increase ...